top of page
IMG_2008.jpg

Is Poised To Amaze

SOON

Who We Are

Despite a crowded market of FDA / EMA approved medications today that have the ability to reduce MS relapses to near 0, there remains a significant unmet need for disease modifying drugs (DMDs) that truly impact MS progression.  RG Therapeutics is a clinical stage biotechnology company that was created to develop such agents.

bottom of page